By Health Capital Consultants, LLC
***
***
On September 5, 2025, the Federal Trade Commission (FTC) voted to dismiss its appeals in two court cases, effectively terminating the Biden Administration’s pursuit of a comprehensive noncompete ban. The 3-1 Commission vote represents a fundamental shift in federal competition enforcement strategy.
This Health Capital Topics article reviews the history of the noncompete ban, the FTC’s recent activities regarding competition, and the implications for healthcare organizations. (Read more…)
COMMENTS APPRECIATED
Like, Refer and Subscribe
***
Filed under: iMBA, Inc. |















Leave a comment